Andrew McKibben | Vice President-Investor Relations and Finance |
Chris Peetz | President and Chief Executive Officer |
Peter Radovich | Chief Operating Officer |
Pam Vig | Head-Research and Development |
Steve Seedhouse | Raymond James |
Mani Foroohar | SVB Leerink |
Thomas Yip | H.C. Wainwright |
Good afternoon, and thank you all for joining. I would like to welcome you all to the Mirum Pharmaceuticals Report Second Quarter 2023 Financial Results and Provide Business Update. My name is Brika, and I’ll be your moderator for today’s call. [Operator Instructions]
I would now like to turn the call over to Andrew McKibben, VP of Investor Relations and Finance.